Updates are available Correction dated 2024-08-01
Click to view Correction: https://doi.org/10.1038/s41586-024-07838-7
-
Authors
Lindeboom, Rik G. H. http://orcid.org/0000-0002-3660-504X
Worlock, Kaylee B. http://orcid.org/0000-0002-5656-7634
Dratva, Lisa M. http://orcid.org/0000-0002-2873-6787
Yoshida, Masahiro http://orcid.org/0000-0002-3521-5322
Scobie, David
Wagstaffe, Helen R. http://orcid.org/0000-0002-4462-7484
Richardson, Laura http://orcid.org/0000-0002-8075-3816
Wilbrey-Clark, Anna
Barnes, Josephine L. http://orcid.org/0000-0001-9938-3176
Kretschmer, Lorenz http://orcid.org/0000-0003-0987-8429
Polanski, Krzysztof http://orcid.org/0000-0002-2586-9576
Allen-Hyttinen, Jessica http://orcid.org/0000-0003-4644-0362
Mehta, Puja http://orcid.org/0000-0001-9459-9306
Sumanaweera, Dinithi
Boccacino, Jacqueline M. http://orcid.org/0000-0001-6813-5217
Sungnak, Waradon http://orcid.org/0000-0002-0136-4960
Elmentaite, Rasa http://orcid.org/0000-0001-7366-5466
Huang, Ni http://orcid.org/0000-0001-8849-038X
Mamanova, Lira
Kapuge, Rakesh http://orcid.org/0009-0001-3394-0387
Bolt, Liam http://orcid.org/0000-0001-7293-0774
Prigmore, Elena http://orcid.org/0000-0001-8870-0316
Killingley, Ben
Kalinova, Mariya
Mayer, Maria
Boyers, Alison
Mann, Alex
Swadling, Leo http://orcid.org/0000-0002-0537-6715
Woodall, Maximillian N. J.
Ellis, Samuel
Smith, Claire M. http://orcid.org/0000-0002-8913-0009
Teixeira, Vitor H. http://orcid.org/0000-0003-0090-861X
Janes, Sam M. http://orcid.org/0000-0002-6634-5939
Chambers, Rachel C. http://orcid.org/0000-0003-1370-9417
Haniffa, Muzlifah http://orcid.org/0000-0002-3927-2084
Catchpole, Andrew
Heyderman, Robert http://orcid.org/0000-0003-4573-449X
Noursadeghi, Mahdad http://orcid.org/0000-0002-4774-0853
Chain, Benny http://orcid.org/0000-0002-7417-3970
Mayer, Andreas http://orcid.org/0000-0002-6643-7622
Meyer, Kerstin B. http://orcid.org/0000-0001-5906-1498
Chiu, Christopher http://orcid.org/0000-0003-0914-920X
Nikolić, Marko Z. http://orcid.org/0000-0001-6304-6848
Teichmann, Sarah A. http://orcid.org/0000-0002-6294-6366
- License Information
-
More Information
Article History
Received: 24 February 2023
Accepted: 16 May 2024
First Online: 19 June 2024
Change Date: 1 August 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-024-07838-7
Competing interests
: R.G.H.L., L.M.D., R.E. and S.A.T. are inventors on a filed patent that is related to the detection and application of activated T cells. In the past 3 years, S.A.T. has received remuneration for scientific advisory board membership from Sanofi, GlaxoSmithKline, Foresite Labs and Qiagen. S.A.T. is a co-founder and holds equity in Transition Bio and Ensocell. From 8 January 2024, S.A.T. is a part-time employee of GlaxoSmithKline. R.E. is a co-founder and equity holder in Ensocell. P.M. is a Medical Research Council (MRC)-GlaxoSmithKline EMINENT clinical training fellow with project funding unrelated to the topic of this work and receives co-funding from the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre. P.M. reports consultancy fees from SOBI, AbbVie, UCB, Lilly, Boehringer Ingelheim and EUSA Pharma, all unrelated to this study. S.M.J. has received fees for advisory board membership in the last three years from Bard1 Lifescience. He has received grant income from GRAIL Inc. He is an unpaid member of a GRAIL advisory board. He has received lecture fees for academic meetings from Cheisi and AstraZeneca. His wife works for AstraZeneca. R.C.C. has research collaborations with Chiesi Chiesi Farmaceutici S.p.A. and GSK and receives consulting fees from Vicore, outside the submitted work. A. Mann, A.C., M.K., M.M. and A.B. are full-time employees at hVIVO Services. The other authors declare no competing interests.
